RealFeedApp beta
Top science & technology news, August 18, 2026
- Delivery of small interfering RNA and antisense oligonucleotides across the blood-brain barrier with monovalent transferrin receptor 1 binding VHH-Fc fusion proteins
A method using VHH-Fc fusion proteins targeting TfR1 enables efficient delivery of oligonucleotides across the blood-brain barrier into the central nervous system.
- Exercise intensity modulates interorgan communication and is associated with
Study shows exercise intensity affects interorgan communication and is linked to longevity.
- GPT-5.6 Sol Pricing Cut by 50%
GPT-5.6 Sol is the flagship model in OpenAI's GPT-5.6 series, designed for complex reasoning, coding, and agency workflows. It excels at command-line and multi-step coding tasks and long-horizon problem solving.
- BCIJelly: An integrated ecosystem for brain-computer interface research
BCIJ, a unified ecosystem, standardizes BCI datasets and integrates decoders, modules, and automated architecture search for efficient BCI research.
- Asia’s longevity gains must be translated into better health
Asia's gains in longevity must be translated into better health to achieve sustainable progress.
- AlzeCure’s $12m payday fuels new brain-aging therapy
A Danish biotech received $12 million for AlzeCure’s drug platform, which could reshape the treatment of Alzheimer’s and Parkinson’s.
- Compact type ii-c cas9 nucleases with expanded pam access and high fidelity for therapeutic genome editing
Researchers identified three new compact type ii-c cas9 variants with improved pam compatibility and reduced off-target effects, enhancing genome editing precision for therapeutic applications.
- Nanopore sequencing measures chromosome end-specific telomere lengths in human cells
A new method using nanopore sequencing measures telomere lengths at chromosome ends. Telomere length impacts human health, and accurate measurement is crucial for understanding age-related diseases and cancer.
- Amylyx prepares for approval push after GLP-1 inhibitor halves blood sugar crashes in phase 3 trial
GLP-1 inhibitor from Amylyx cut dangerous blood sugar crashes by more than half in patients with a rare endocrine disease.
- TechCrunch Disrupt 2026 Passes Available for Up to $300 Off Until August 21
TechCrunch Disrupt 2026 passes are available for up to $300 off until August 21 at 11:59 PM PT. After this deadline, the chance to save on your pass or get even larger discounts on group pricing will be over.
- zenDot: An LLM-integrated quantum TCAD platform for semiconductor quantum-device design and optimization automation
zenDot is a quantum TCAD platform integrating LLMs to automate the design and optimization of semiconductor quantum devices.
- Virus-like particle-delivered base editors expand genome engineering tools
Researchers tested 12 base editors on a v5 eVLP backbone, showing editing efficiency depends on dosage and editor type.
- Lifespan brain structural variation reveals shared organization across mental health conditions
The study finds that brain structural variations across mental health conditions follow a shared organizational pattern, suggesting common vulnerabilities.
- Measuring Obedience to Authority Across LLMs with the Milgram Paradigm
Researchers adapt Milgram's obedience paradigm to assess how far LLMs will escalate harmful actions under authority pressure.
- Three Former SpaceX Engineers Build Robotic Factory for Steel Parts Production
Three former SpaceX engineers have switched their focus from rocket engine production to steel part manufacturing using AI-driven software and robots. Their goal is to establish a prototype factory capable of automating most of the steel fabrication process by 2027.
- Large Language Models Show Metacognitive Sensitivity in Medical Reasoning
Research shows large language models can assess answer accuracy and confidence in medical diagnostics, which is crucial for clinical applications.
- Retrieval-Augmented Large Language Models for Clinically Aligned Adverse Event Coding in Acute Myeloid Leukemia Clinical Trials
The study shows how retrieval-augmented large language models can improve automated adverse event coding in clinical trials for acute myeloid leukemia.
- Microsoft Copilot reveals secret input that allowed it to be hacked
Researchers exploited a vulnerability in Microsoft Copilot Enterprise by using the LLM itself as a source of sensitive data.
- Reach Capital raises $265M Fund V to back AI founders building to ‘expand human potential’
Reach Capital closed a $26,500,000 Fund V to support AI founders building applications that expand human potential.
- Amylyx to share Phase 3 results for low blood sugar treatment after weight loss surgery
Amylyx Pharmaceuticals will announce top-line results from its Phase 3 Lucidity trial of Avexitide for post-bariatric hypoglycemia on August 18, 2026.
